The Chart of the Day belongs to CymaBay Therapeutics (CBAY). I found the biopharmaceutical stock by using Barchart to sort today's Top Stocks to Ownlist first by the highest Weighted Alpha, then I used the Flipchart feature to review the charts for consistent price appreciation. Since the Trend Spotter signaled a buy on 12/22 the stock gained 15.36%.
CymaBay Therapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of proprietary new medicines for important human diseases. The Company's lead product candidate, arhalofenate, is being developed for the treatment of gout. CymaBay Therapeutics Inc. is based in Newark, California.
updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates.
technical indicators:
311.52+ Weighted Alpha
100% technical buy signals
Trend Spotter buy signal
Above its 20, 50 and 100 day moving averages
7 new highs and up 15.25%
Technical support level at 10.23
Recently traded at 10.72 with a 50 day moving average of 8.95
Fundamental factors:
Market cap $458 million
Despite weak Revenue and earnings projections Wall Street analysts issued 6 strong buy recommendations